Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI

Ibanez, 2018, 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, 39, 119, 10.1093/eurheartj/ehx393 Palmerini, 2013, Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis, J Am Coll Cardiol, 62, 496, 10.1016/j.jacc.2013.05.022 Yerasi, 2020, Drug-coated balloon for de novo coronary artery disease: JACC state-of-the-art review, J Am Coll Cardiol, 75, 1061, 10.1016/j.jacc.2019.12.046 Merinopoulos, 2018, Percutaneous coronary intervention in the elderly: are drug-coated balloons the future?, Curr Cardiol Rev, 14, 45, 10.2174/1573403X14666171226144120 Jeger, 2020, Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group, J Am Coll Cardiol Intv, 13, 1391, 10.1016/j.jcin.2020.02.043 Rissanen, 2019, Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial, Lancet, 394, 230, 10.1016/S0140-6736(19)31126-2 Jeger, 2018, Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label non-inferiority trial, Lancet, 6736, 1 Neumann, 2019, 2018 ESC/EACTS guidelines on myocardial revascularization, Eur Heart J, 40, 87, 10.1093/eurheartj/ehy394 Merinopoulos, 2022, Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice, Clin Res Cardiol, 10.1007/s00392-022-02106-y Merinopoulos, 2021, Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study, Clin Res Cardiol, 110, 220, 10.1007/s00392-020-01734-6 Ho, 2015, Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention, World J Cardiol, 7, 311, 10.4330/wjc.v7.i6.311 Teacher, 2021, Study on the safety and effectiveness of drug-coated balloons in patients with acute myocardial infarction, J Cardiothorac Surg, 16, 1 Nijhoff, 2015, Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (Drug-Eluting Balloon in ST-Segment Elevation Myocardial Infarction) trial, Catheter Cardiovasc Interv, 86, S34, 10.1002/ccd.26060 Garcia-Garcia, 2018, Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document, Circulation, 137, 2635, 10.1161/CIRCULATIONAHA.117.029289 Gilbert, 2018, Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study, Lancet, 391, 1775, 10.1016/S0140-6736(18)30668-8 Mehran, 2010, A risk score to predict bleeding in patients with acute coronary syndromes, J Am Coll Cardiol, 55, 2556, 10.1016/j.jacc.2009.09.076 Grines, 1993, A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction, N Engl J Med, 328, 673, 10.1056/NEJM199303113281001 Zijlstra, 2000, Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction, Eur Heart J, 21, 1487, 10.1053/euhj.2000.2192 Bangalore, 2013, Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials, Circ Cardiovasc Interv, 6, 378, 10.1161/CIRCINTERVENTIONS.113.000415 Chichareon, 2019, Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction, J Am Coll Cardiol, 74, 2572, 10.1016/j.jacc.2019.09.038 Vos, 2019, Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial, J Am Coll Cardiol Intv, 12, 1691, 10.1016/j.jcin.2019.04.016 Gobić, 2017, Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: a feasibility study, Am J Med Sci, 354, 553, 10.1016/j.amjms.2017.07.005 Ludman Urban, 2019, Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk, Eur Heart J, 40, 2632, 10.1093/eurheartj/ehz372